STIM1 and triple-negative breast carcinoma: More recently, Chakraborty and coworkers have reported that phemindole, a synthetic di-indole derivative with anti-carcinogenic activity in triple negative breast cancer cells, reduces SOCE by down-regulation of STIM1 expression [74].